Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-27
DOI
10.3389/fpsyt.2019.00093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
- (2018) Akiko Matsuura et al. Scientific Reports
- D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia?
- (2018) Paul J. Harrison BIOLOGICAL PSYCHIATRY
- A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia
- (2017) Handan Gunduz-Bruce et al. EXPERIMENTAL PHYSIOLOGY
- Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms
- (2017) I-Hua Wei et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
- (2017) Philippe Conus et al. SCHIZOPHRENIA BULLETIN
- Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
- (2017) Chieh-Hsin Lin et al. Scientific Reports
- Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
- (2017) James Maksymetz et al. Molecular Brain
- Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker
- (2016) Esra Soydaş Akyol et al. ACTA NEUROPSYCHIATRICA
- Decreased mRNA expression for the two subunits of system xc−, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia
- (2016) Chieh-Hsin Lin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
- (2016) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- The association between cognitive deficits and prefrontal hemodynamic responses during performance of working memory task in patients with schizophrenia
- (2016) Shenghong Pu et al. SCHIZOPHRENIA RESEARCH
- Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?
- (2016) P. Steullet et al. SCHIZOPHRENIA RESEARCH
- Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker
- (2016) Esra Soydaş Akyol et al. ACTA NEUROPSYCHIATRICA
- Impaired Attention and Synaptic Senescence of the Prefrontal Cortex Involves Redox Regulation of NMDA Receptors
- (2015) M. Guidi et al. JOURNAL OF NEUROSCIENCE
- Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
- (2015) Y Iwata et al. MOLECULAR PSYCHIATRY
- NMDA Pathology and Treatment of Schizophrenia
- (2014) Huey-Jen Chang et al. CURRENT PHARMACEUTICAL DESIGN
- Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia
- (2014) Jing Qin Wu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Accelerated white matter aging in schizophrenia: role of white matter blood perfusion
- (2014) Susan N. Wright et al. NEUROBIOLOGY OF AGING
- Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project
- (2014) Diana O. Perkins et al. SCHIZOPHRENIA BULLETIN
- Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia — An observational 9-year follow-up study
- (2014) Anja P. Husa et al. SCHIZOPHRENIA RESEARCH
- Accelerated Aging in Schizophrenia Patients: The Potential Role of Oxidative Stress
- (2014) Aging and Disease
- Meta-Analysis of Oxidative Stress in Schizophrenia
- (2013) Joshua Flatow et al. BIOLOGICAL PSYCHIATRY
- Domain-specific suppression of auditory mismatch negativity with transcranial direct current stimulation
- (2013) J.C. Chen et al. CLINICAL NEUROPHYSIOLOGY
- The C-Terminal Region of G72 Increases D-Amino Acid Oxidase Activity
- (2013) Sunny Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bi-directional modulation of somatosensory mismatch negativity with transcranial direct current stimulation: an event related potential study
- (2013) Jui-Cheng Chen et al. JOURNAL OF PHYSIOLOGY-LONDON
- Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
- (2013) C-H Lin et al. MOLECULAR PSYCHIATRY
- Kainate Receptors in Health and Disease
- (2013) Juan Lerma et al. NEURON
- Allopregnanolone and puberty: Modulatory effect on glutamate and GABA release and expression of 3α-hydroxysteroid oxidoreductase in the hypothalamus of female rats
- (2013) F.A. Giuliani et al. NEUROSCIENCE
- Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders
- (2013) G. A. Light et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence Base for Using Atypical Antipsychotics for Psychosis in Adolescents
- (2013) S. S. Datta et al. SCHIZOPHRENIA BULLETIN
- Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia
- (2013) Janusz Tucholski et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Prediction and Prevention of Psychosis in Youth at Clinical High Risk
- (2012) Jean Addington et al. Annual Review of Clinical Psychology
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia
- (2010) Kodavali V. Chowdari et al. ANTIOXIDANTS & REDOX SIGNALING
- Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
- (2010) Daisuke Matsuzawa et al. ANTIOXIDANTS & REDOX SIGNALING
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Intracellular Redox State Alters NMDA Receptor Response during Aging through Ca2+/Calmodulin-Dependent Protein Kinase II
- (2010) K. Bodhinathan et al. JOURNAL OF NEUROSCIENCE
- Schizophrenia: The drug deadlock
- (2010) Alison Abbott NATURE
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Disorganization/Cognitive and Negative Symptom Dimensions in the At-Risk Mental State Predict Subsequent Transition to Psychosis
- (2010) A. Demjaha et al. SCHIZOPHRENIA BULLETIN
- The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia
- (2009) Yin-Ju Lien et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Redox dysregulation, neurodevelopment, and schizophrenia
- (2009) Kim Q Do et al. CURRENT OPINION IN NEUROBIOLOGY
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Synaptic AMPA Receptor Plasticity and Behavior
- (2009) Helmut W. Kessels et al. NEURON
- The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats
- (2009) Shii-Yi Yang et al. NEUROSCIENCE LETTERS
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycine Transport Inhibitors and the Treatment of Schizophrenia
- (2008) Daniel C. Javitt BIOLOGICAL PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)
- (2008) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
- (2008) P. Jeffrey Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started